Literature DB >> 26608284

Reestablishment of the hyperglycemia to the normal levels seems not to be essential to the anxiolytic-like effect induced by insulin.

Eder Gambeta1, Camila Pasquini de Souza1, Helen de Morais1, Janaina Menezes Zanoveli2.   

Abstract

Diabetes is a chronic metabolic disease accompanied by several comorbidities, including neuropsychiatric conditions. Since the hyperglycemia appears to be the primary factor involved in diabetic conditions, we examined the effect of insulin treatment in diabetic rats on behavioral responses related to anxiety and aversive memory extinction. For this, normoglycemic (NGL) or streptozotocin-diabetic (DBT) rats were submitted to the elevated T maze (ETM) and the contextual conditioned fear (CCF) tests. Therefore, animals were subjected to the prolonged treatment with insulin (6 IU/day, s.c.) to investigate the effect of the treatment on distinct behaviors. When anxiety-like responses such as the inhibitory avoidance (IA) on the ETM and the time of freezing in the first session of the CCF test were evaluated, our data showed a more pronounced anxiogenic-like behavior in DBT animals when compared to NGL ones. In addition, an increased freezing time was observed in DBT animals exposed to the CCF test (sessions 2 and 3) when compared to the NGL group, suggestive of an impairment in the extinction of aversive memory. Insulin treatment induced an anxiolytic-like effect when IA and freezing time (session 1) was evaluated, but did not alter the impaired extinction of aversive memory (sessions 2 and 3). To better understand the involvement of a rigorous control of glycaemia, we also investigated the effect of a lower dose of insulin (3 IU/day, s.c.), unable to reestablish the hyperglycemia to the normal levels, on the same behavioral parameters. Our data show that independent of the dose of insulin, the same effects were observed when animals were evaluated in the ETM and CCF tests. However, only the highest dose of insulin was able to reduce the hyperglycemia to the normal levels. To conclude, our data suggest that a severe glycemic control by insulin treatment seems to be important, but not essential in improving diabetes-induced anxiety.

Entities:  

Keywords:  Anxiety; Aversive memory extinction; Diabetes; Glycemic levels; Insulin

Mesh:

Substances:

Year:  2015        PMID: 26608284     DOI: 10.1007/s11011-015-9770-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  64 in total

1.  The prevalence of depression and anxiety in adults with Type 1 diabetes.

Authors:  M C Shaban; J Fosbury; D Kerr; D A Cavan
Journal:  Diabet Med       Date:  2006-12       Impact factor: 4.359

2.  Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice.

Authors:  Deepali Gupta; Mahesh Radhakrishnan; Yeshwant Kurhe
Journal:  Metab Brain Dis       Date:  2014-04-25       Impact factor: 3.584

3.  Passive and active reactions to fear-eliciting stimuli.

Authors:  R J Blanchard; D C Blanchard
Journal:  J Comp Physiol Psychol       Date:  1969-05

4.  Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.

Authors:  J M Zanoveli; R L Nogueira; H Zangrossi
Journal:  Behav Pharmacol       Date:  2005-11       Impact factor: 2.293

5.  Impact of diabetes on CNS: role of signal transduction cascade.

Authors:  S K Bhardwaj; S K Sandhu; P Sharma; G Kaur
Journal:  Brain Res Bull       Date:  1999-06       Impact factor: 4.077

6.  Association of depression and diabetes complications: a meta-analysis.

Authors:  M de Groot; R Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

Review 7.  Oxidative stress, nitric oxide, and diabetes.

Authors:  Dario Pitocco; Francesco Zaccardi; Enrico Di Stasio; Federica Romitelli; Stefano A Santini; Cecilia Zuppi; Giovanni Ghirlanda
Journal:  Rev Diabet Stud       Date:  2010-05-10

Review 8.  The role of GABA in the pathophysiology and treatment of anxiety disorders.

Authors:  Charles B Nemeroff
Journal:  Psychopharmacol Bull       Date:  2003

9.  Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

Authors:  George J Francis; Jose A Martinez; Wei Q Liu; Kevin Xu; Amit Ayer; Jared Fine; Ursula I Tuor; Gordon Glazner; Leah R Hanson; William H Frey; Cory Toth
Journal:  Brain       Date:  2008-11-16       Impact factor: 13.501

10.  Alterations in hippocampal serotonergic and INSR function in streptozotocin induced diabetic rats exposed to stress: neuroprotective role of pyridoxine and Aegle marmelose.

Authors:  Pretty Mary Abraham; Korah P Kuruvilla; Jobin Mathew; Anitha Malat; Shilpa Joy; C S Paulose
Journal:  J Biomed Sci       Date:  2010-09-25       Impact factor: 8.410

View more
  4 in total

1.  Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.

Authors:  Yane Costa Chaves; Karina Genaro; José Alexandre Crippa; Joice Maria da Cunha; Janaína Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2021-01-19       Impact factor: 3.584

2.  A single injection of pregabalin induces short- and long-term beneficial effects on fear memory and anxiety-like behavior in rats with experimental type-1 diabetes mellitus.

Authors:  Alvaro Henrique Bernardo de Lima Silva; Debora Rasec Radulski; Gabriela Saidel Pereira; Alexandra Acco; Janaina Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2022-03-03       Impact factor: 3.584

3.  Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model.

Authors:  Felipe Fagundes Leão; Ana Paula Farias Waltrick; Waldiceu Aparecido Verri; Joice Maria da Cunha; Janaina Menezes Zanoveli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-19       Impact factor: 3.195

4.  The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes.

Authors:  Mariana Machado Pereira; Helen de Morais; Eldevan Dos Santos Silva; Claudia Rita Corso; Eliana Rezende Adami; Rose Maria Carlos; Alexandra Acco; Janaina Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2018-06-23       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.